FUNDING News
Axoft Raises $55M Series A for Implantable Brain-Computer Interfaces
Axoft has successfully secured $55 million in an oversubscribed Series A funding round, led by C.P. Group Innovation. This capital will be used to expand global clinical trials and advance U.S. regula
Chai Discovery Secures $400M Series C for AI-Driven Drug Design
Chai Discovery, an AI-enabled drug design company, has successfully closed a $400 million Series C financing round, bringing its valuation to $3.8 billion. This significant funding will support the co
Chai Discovery Secures $400M Funding, Valuation Reaches $3.8B
AI drug discovery startup Chai Discovery has secured $400 million in new funding, tripling its valuation to $3.8 billion in just seven months. The round was led by Index Ventures, with previous suppor
Israel Invests NIS 70M in National AI Bio Data Consortium for Drug Discovery
The Israel Innovation Authority announced a NIS 70 million investment (approximately $23.2 million USD) to establish the Israel BioToken Factory Initiative (IBFI). This national R&D consortium aims to
MindRank AI Secures $52M Series B for AI-Native Drug Development
MindRank AI, a clinical-stage biotechnology firm, has successfully raised $52 million in Series B funding. This capital infusion will be utilized to further develop its proprietary Molecule Arts Platf
AI Drug Discovery and Longevity Startups Secure Major VC Funding in H1 2026
AI drug discovery company Isomorphic Labs raised $2.1 billion, while longevity startup NewLimit secured $435 million, marking some of the largest venture rounds in the first half of 2026. These substa
$60K Scialog Award Fuels LLNL Automation Research
Lawrence Livermore National Laboratory scientist Johanna Schwartz has received a $60,000 Scialog Award to further research into laboratory automation. This funding highlights a focused investment in i
Absci Raises $100 Million to Advance AI-Designed Therapeutics for Hair Loss and Endometriosis
Absci Corporation, a biopharmaceutical company leveraging generative AI for drug discovery, has successfully priced an underwritten public offering, raising approximately $100 million. The funding, ba
Absci Secures $100M Lilly-Backed Raise, Reports Positive Hair Loss Drug Data
Absci Corporation announced positive early results from a clinical trial of its AI-designed experimental drug, ABS-201, for pattern hair loss, showing it was well-tolerated and had a long-lasting pres
AMI Labs Secures $1B Seed Funding for AI World Models in Healthcare, Robotics
AMI Labs, co-led by AI pioneer Yann LeCun and CEO Alexandre LeBrun, has successfully closed a $1.03 billion seed funding round, achieving a $3.5 billion valuation. This substantial investment, backed
Anti-aging startup NewLimit raises $435M at $3B+ valuation, eyes clinic in 2027
NewLimit, an anti-aging startup, has secured a significant $435 million Series C funding round, pushing its valuation past $3 billion. This substantial investment will accelerate the development of it
Isomorphic Labs Secures Over $2B to Scale AI Drug Discovery Platform
Alphabet's Isomorphic Labs, a Google DeepMind spin-off, has raised over $2 billion in new funding to expand its AI drug discovery engine beyond protein structure prediction. The significant Series B r
Isomorphic Labs Secures $2.1 Billion Series B for AI Drug Discovery
Isomorphic Labs, an AI drug discovery firm, has successfully raised $2.1 billion in a Series B funding round. The substantial investment, led by Thrive Capital and including participation from MGX and
Isomorphic Labs Secures $2.1B Series B for AI Drug Discovery Scale-Up
Isomorphic Labs, an AI-driven drug discovery company and a spin-off of Google DeepMind, has successfully raised $2.1 billion in Series B financing. This substantial investment will be utilized to furt
Isomorphic Labs Secures $2.1 Billion Series B for AI Drug Discovery
Alphabet's AI-driven drug discovery company, Isomorphic Labs, has raised $2.1 billion in a Series B funding round. This substantial investment, led by Thrive Capital, will be used to advance its pipel
Isomorphic Labs Secures $2.1 Billion in Series B Funding for AI Drug Discovery
Isomorphic Labs, an Alphabet-backed company focused on leveraging artificial intelligence for drug discovery, has successfully closed a $2.1 billion Series B funding round. This substantial investment
Isomorphic Labs Raises $2.1B Series B for AI Drug Design Engine
Isomorphic Labs, an Alphabet subsidiary, has secured $2.1 billion in Series B funding to advance its AI-first drug design and development platform. Led by Thrive Capital, this significant investment w
Isomorphic Labs Secures $2.1 Billion for AI Drug Design Engine
Isomorphic Labs, an AI-first drug design and development company spun off from Google DeepMind, has closed a $2.1 billion Series B funding round. Led by Thrive Capital, with participation from Alphabe
Isomorphic Labs Secures $2.1B Series B for AI Drug Discovery
Isomorphic Labs, an Alphabet-backed company, has raised $2.1 billion in Series B funding led by Thrive Capital. This significant investment aims to accelerate the firm's AI-driven drug discovery effor
Google's Isomorphic Labs to raise over $2 billion in new funding
Isomorphic Labs, Alphabet's AI drug discovery firm, is reportedly in advanced discussions to secure over $2 billion in a new funding round. Led by Thrive Capital with participation from Alphabet, this
Basata Secures $21M Series A for AI in Healthcare Automation
Basata announced a successful $21 million Series A funding round, led by Basis Set Ventures, to advance its AI-powered platform for automating healthcare administrative workflows. The company's AI age
Tempus Secures $400 Million in Upsized Convertible Senior Notes Offering
Tempus AI, a technology company focused on advancing precision medicine through artificial intelligence, has priced an upsized offering of $400.0 million in convertible senior notes due 2032. The net
Google's Isomorphic Labs seeks $2B to scale AI drug discovery efforts
Isomorphic Labs, the Alphabet-owned company focused on leveraging AI for drug discovery, is reportedly seeking over $2 billion in new funding. This significant capital raise highlights the increasing
Biohub Commits $500M to AI for Predictive Human Cell Models
The Chan Zuckerberg Biohub has launched a $500 million Virtual Biology Initiative to create AI-powered predictive models of the human cell. This global effort, in collaboration with institutions like
Turkey-Based Biotech Startup PhiTech Raises $2.4M for Precision Medicine
PhiTech, a Turkish deep-tech biotech startup, has successfully raised $2.4 million in its third funding round. This investment will fuel the development and global patenting of its AI-based multi-omic
Generare Secures €20M Series A for AI-Driven Drug Discovery
Paris-based techbio company Generare has successfully raised €20 million in Series A funding, co-led by Alven and Daphni. This investment will enable the company to expand its proprietary dataset of s
Generare raises $23.2M for AI drug discovery of novel molecules
Generare Bioscience SAS, a Paris-based biotechnology company, has successfully closed a Series A funding round, raising €20 million (approximately $23.3 million). The financing, co-led by Alven and Da
EvoBio AI Secures $50M Series B for Generative Protein Design Platform
EvoBio AI, a biotechnology startup leveraging generative AI for novel protein design, announced a $50 million Series B funding round. The investment will accelerate the development of its platform, wh
Earendil Labs, an AI-powered drugmaker, hauls in $787M
Earendil Labs, an AI-powered startup with a presence in China and the U.S., has secured $787 million in funding to advance its pipeline of biologic medicines for autoimmune conditions and cancer. The
Earendil Labs Secures $787M for AI-Powered Biologic Drug Discovery
Earendil Labs, an AI-powered drug discovery startup operating in both China and the U.S., has successfully raised $787 million in funding. This substantial investment, backed by firms like Dimension a
Verily Secures $300M for Precision Health AI, Alphabet Shifts Role
Verily, formerly an Alphabet company, has secured a significant $300 million investment round led by Series X Capital, with Alphabet transitioning to a significant minority investor. This funding will
metaBIX Biotech Raises $1.3M for AI Biosurveillance
Uruguayan deeptech startup metaBIX Biotech has successfully closed a $1.3 million funding round led by Dalus Capital and EWA Capital, with participation from existing investors. This investment will f
Owkin Spinout Waiv Raises $33M for AI-Powered Cancer Precision Testing
French AI biotech Owkin has spun out its diagnostics division, now named Waiv, securing $33 million in Series A funding. Led by OTB Ventures and Alpha Intelligence Capital, Waiv will focus on scaling
Alibaba Leads $72.7M Investment in BCI Startup StairMed
StairMed, a Brain-Computer Interface (BCI) developer, has successfully closed a RMB 500 million (USD 72.7 million) funding round. This significant investment was led by Alibaba Group, with additional
CRISPR Therapeutics Plans $350 Million Private Debt Offering
CRISPR Therapeutics announced plans for a private offering of $350 million in convertible senior notes, scheduled to mature in 2031. This funding initiative aims to support the company's ongoing gene-
Neurotech Startup Science Corp. Secures $230M at $1.5B Valuation
Science Corp., a neurotech startup dedicated to restoring eyesight, has successfully raised $230 million in a new funding round. This significant investment has boosted the company's valuation to $1.5
Bill Gates Awards $7M Grant to Belgian Startup Using AI for Climate-Resilient Crops
Belgian agtech firm Rainbow Crops has been awarded a $7 million grant from the Gates Foundation to advance its AI-driven technology for creating climate-resilient and high-yielding crops. The funding
Cognito Therapeutics Closes $105M Series C, Nexcure Raises $19M Series A
Cognito Therapeutics has successfully closed an oversubscribed $105 million Series C financing round, aimed at accelerating its neurodegenerative disease programs. Concurrently, Nexcure launched a $19
Syndex Bio closes $15.5M seed round, unveils mcPCR platform
Syndex Bio, a Cambridge, UK-based biotech startup, successfully closed an oversubscribed $15.5 million seed financing round led by ARCH Venture Partners. The company also unveiled its methyl-copying P
Paris' baCta Raises €7M Seed for AI-Powered Bioproduction
Paris-based industrial biotech startup baCta secured €7 million in seed funding led by LocalGlobe and Daphni. The company focuses on using AI-powered bioproduction to create industrial ingredients, ai
Deepinder Goyal's Temple Raises $54M for Brain-Monitoring Wearable
Deepinder Goyal, co-founder of Zomato, has secured $54 million in a seed funding round for his new wearable technology startup, Temple. The company is developing a high-performance wearable device des
Kerala University Boosts AI Research in Cancer, Cardiac Care
Kerala University's 2026-27 budget includes significant funding to advance AI-driven cancer and cardiac research, as well as introduce 40 new postgraduate programs in emerging interdisciplinary domain
DeepCell AI Secures $75M Series C to Advance Single-Cell Analysis
DeepCell AI has successfully closed a $75 million Series C funding round to accelerate the development and deployment of its AI-powered platform for high-throughput single-cell classification and phen
BioSynth AI Secures $5M Seed to Boost Generative Enzyme Design Platform
BioSynth AI, a pioneering biotechnology startup, has successfully closed a $5 million seed funding round, led by XYZ Ventures. This capital infusion will accelerate the development and expansion of it
Generate Biomedicines' $400M IPO Puts AI Drug Discovery in Focus
Generate Biomedicines, an AI-driven drug developer, successfully completed its U.S. initial public offering (IPO) on February 26, 2026, raising $400 million. The company sold 25 million shares at $16
Generate Biomedicines Raises $400M in Largest Biotech IPO
AI drug discovery specialist Generate Biomedicines raised $400 million in the year's largest biotechnology initial public offering, selling 25 million shares at $16 each. Their shares began trading on
Turbine Secures $25M Series B, Announces New Top 10 Pharma Immunology Partnership
Turbine, a virtual biology company, has successfully closed a $25 million Series B funding round led by Interactive Venture Partners, with participation from Beiersdorf AG and existing investors. This
Turbine Secures $25M Series B for AI Virtual Biology, Expands to Immunology
Budapest-based Turbine, a virtual biology company, has successfully closed a $25 million Series B funding round to further develop its AI-powered virtual cell platform. The company also announced a ne
Peptris Secures $7.7M Series A for AI Drug Discovery Programs
Bengaluru-based Peptris has closed a $7.7 million Series A funding round, co-led by IAN Alpha Fund and Speciale Invest. This capital injection will accelerate the company's AI-powered drug discovery i
GenoAI Therapeutics Secures $50M Series B for AI Precision Oncology
GenoAI Therapeutics announced a successful $50 million Series B funding round led by Venture Health Capital. This capital infusion will accelerate the development and expansion of its AI-powered platf